Literature DB >> 6444306

Studies of T- and B-cell interactions in adult patients with combined immunodeficiency.

T Morito, A D Bankhurst, R C Williams.   

Abstract

Cellular interactions involved in the pathogenesis of hypogammaglobulinemia were studied in six patients with common variable immunodeficiency. Amounts of immunoglobulin (Ig)G and IgM in the supernate of pokeweed mitogen-stimulated cocultures of normal and immunodeficient mononuclear cells were measured by radioimmunoassays. Mononuclear cells from three of six patients inhibited Ig production of normal B cells (P < 0.005). When purified patient and normal T cells were added to B cells in various autologous or allogeneic combinations, it was observed that immunodeficient T cells (AT) from four patients suppressed normal IgM synthesis. Allogeneic normal T cells did not provide help for B cells from these same immunodeficient patients. In two patients, autologous T cells were able to help autologous B-cell IgM synthesis in vitro. In five patients, AT cells inhibited normal B-cell IgG synthesis. Removal of T cells bearing Ia determinants or T cells with Fc-IgG receptors did not diminish the suppressive effect of AT cells on normal B-cell Ig synthesis. Addition of indomethacin, a prostaglandin synthetase inhibitor, did not abrogate the suppressive effect of immunodeficient mononuclear cells. Addition of hydrocortisone succinate (10 muM) did reverse the suppressive effect of AT cells on IgM production in one patient; however, no in vitro reversal of suppressor cell effect was recorded in five. Suppression by immune-deficient T cells was eliminated by 2,000 rad of x-ray irradiation in three patients. After x-ray irradiation immunedeficient T cells could function as helpers of normal B cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6444306      PMCID: PMC371380          DOI: 10.1172/JCI109685

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Central failure of B-lymphocyte induction in pan-hypogammaglobulinemia.

Authors:  A R Hayward; M F Greaves
Journal:  Clin Immunol Immunopathol       Date:  1975-03

2.  Intracellular immunoglobulin production in vitro by lymphocytes from patients with hypogammaglobulinaemia and their effect on normal lymphocytes.

Authors:  B C Broom; E G De la Concha; A D Webster; G J Janossy; G L Asherson
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

3.  Heterogeneity of "acquired" or common variable agammaglobulinemia.

Authors:  R S Geha; E Schneeberger; E Merler; F S Rosen
Journal:  N Engl J Med       Date:  1974-07-04       Impact factor: 91.245

4.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

5.  The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells.

Authors:  U Galili; M Schlesinger
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

6.  General methods for the study of cells and serum during the immune response: the response to dinitrophenyl in mice.

Authors:  N R Klinman; R B Taylor
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

7.  Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin.

Authors:  J S Goodwin; A D Bankhurst; S A Murphy; D S Selinger; R P Messner; R C Williams
Journal:  J Clin Lab Immunol       Date:  1978-11

8.  Differentiation capacity of cultured B lymphocytes from immunodeficient patients.

Authors:  L Y Wu; A R Lawton; M D Cooper
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

9.  Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera.

Authors:  R Billing; B Rafizadeh; I Drew; G Hartman; R Gale; P Terasaki
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

10.  Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes.

Authors:  R J Winchester; P Wernet; H G Kunkel; B Dupont; C Jersild; S M Fu
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

View more
  6 in total

1.  Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors.

Authors:  L Mayer; S M Fu; C Cunningham-Rundles; H G Kunkel
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

2.  Glucocorticosteroid enhancement of immunoglobulin synthesis by pokeweed mitogen-stimulated human lymphocytes. III. Common variable immunodeficiency.

Authors:  D A Cooper; P Hansen; M Duckett; J B Ziegler; R Penny
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

3.  T lymphocyte subpopulations and Ia-positive T cells in patients with immunodeficiency.

Authors:  R C Williams; A D Webster; T Morito; M F Greaves
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

4.  Lymphocyte cell subpopulations during acute post-streptococcal glomerulonephritis: cell surface antigens and binding of streptococcal membrane antigens and C-reactive protein.

Authors:  R C Williams; I Van de Rijn; H Reid; T Poon-King; J B Zabriskie
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

5.  Immunoglobulin production after marrow transplantation. III. The functional heterogeneity of FC-IgG receptor positive and negative T cell subpopulations.

Authors:  L G Lum; M C Seigneuret; N Orcutt-Thordarson; R C Ostenson; R Storb
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

6.  Autologous mixed lymphocyte reaction in man. IV. Decreased autologous mixed lymphocyte culture response in patients with common variable immunodeficiency.

Authors:  S Gupta; N K Damle
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.